Related Experiment Videos
Validation of the ucla integrated staging system for patients with renal cell carcinoma
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?
Annals of oncology : official journal of the European Society for Medical Oncology·2017
A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer.
Prostate cancer and prostatic diseases·2015
[Ischemia is not an independent predictive factor of chronic renal failure after partial nephrectomy in a solitary kidney in patients without pre-operative renal insufficiency].
Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2014
Assessment of progression-free survival as a surrogate end-point for overall survival in patients with metastatic renal cell carcinoma.
European journal of cancer (Oxford, England : 1990)·2014
Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early-Stage Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Purple Blossoms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Hypoxia-Induced Expression of miR-424, miR-155, CD47, and PD-L1 in a Gastric Cancer Cell Line (MKN-45).
Iranian biomedical journal·2026
Long-term safety of first-line osimertinib plus platinum-pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2.
Lung cancer (Amsterdam, Netherlands)·2026